Vanda eyes first FDA-approved delayed sleep-wake disorder drug0ShareHealthVanda eyes first FDA-approved delayed sleep-wake disorder drug10 sources·Updated Oct 1, 20260Photo: Artem Podrez / Wikimedia Commons (Pexels)SponsoredSponsoredIn this story:🏷️VandaTagWhere do you stand?VandaSupportOpposeMore on this storyBack to NewsTechNscale Names Meta Veteran COO Ahead of IPONscale has appointed former Meta executive Justin Osofsky as COO to oversee global operations as the AI infrastructure company scales its data-center business. The hire comes as Nscale prepares for a New York IPO, reportedly seeking to raise up to $3 billion.6 sourcesBusinessAccenture Outlook Boosts Indian IT SentimentAccenture’s stronger-than-expected fourth-quarter results, robust bookings and forecast of 3% to 6% growth in FY2027 lifted sentiment toward Indian IT stocks, as its rising AI and transformation work suggests global tech demand is holding up. Analysts nevertheless expect a gradual, uneven recovery for Indian providers, with constrained discretionary spending, AI-driven productivity and pricing pressure likely to limit near-term revenue growth.
